DTIL vs IBRX Stock Comparison
Compare DTIL and IBRX across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between DTIL and IBRX?
IBRX leads the current stock comparison as ImmunityBio, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Precision BioSciences, Inc. vs ImmunityBio, Inc.
IBRX leads
IBRX leads by 7 AIQ points, primarily on Quality and Momentum, and the lead has widened from 3 points over 30 sessions. Wall Street currently favors DTIL on target upside.
Fragile: 3 of 6 evidence groups support IBRX, its lead is widening, and its current signal state is conflicted.
Precision BioSciences, Inc.
ImmunityBio, Inc.
The Algovestiq AIQ Score currently favors IBRX over DTIL, 56 versus 49 as of Sep 11, 2026. IBRX's advantage is driven primarily by stronger quality and momentum, while DTIL holds the stronger value profile. IBRX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors DTIL. 3 of 6 covered evidence groups favor IBRX today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. IBRX lead: Strengthening — the AIQ differential moved from 3 to 7 points over 30 sessions.
Compare Precision BioSciences, Inc. and ImmunityBio, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare DTIL and IBRX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality51 vs 100IBRX +49
- Value60 vs 34DTIL +26
- Risk Resilience51 vs 28DTIL +23
- Momentum31 vs 46IBRX +15
3 of 6 evidence groups favor IBRX. IBRX’s edge is concentrated in quality and momentum; DTIL keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
No factor moved materially.
No new signals fired.
Largest factor move: Momentum -15
New signals
- MACD Bearish Crossover — bearish, momentum, short horizon
IBRX's lead narrowed by 4 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — DTIL and IBRX both carry a full feed there.
The central trade-off
IBRX (ImmunityBio, Inc.): the stronger current systematic profile, led by quality and momentum.
DTIL (Precision BioSciences, Inc.): the counter-case, on value, risk resilience, valuation.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
IBRXIBRX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
IBRXIBRX on combined revenue and EPS growth.
Value
DTILDTIL on the peer-relative Value factor, by 26 points.
Momentum
IBRXIBRX on the Momentum factor, by 15 points.
Lower downside
DTILDTIL on Risk Resilience, by 23 points.
Analyst upside
DTILDTIL on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors IBRX, analyst targets favor DTIL. That disagreement is the most useful thing on this page.
| Measure | DTIL | IBRX | Note |
|---|---|---|---|
| Implied upside to target | +178.9% | +51.7% | DTIL has more room |
| Target dispersion | 0% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 1 | 1 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor IBRX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | IBRX | 49 vs 56 |
| Fundamentals | IBRXon balance | revenue growth -100% vs 15.9%; EPS growth -68% vs 64.5%; TTM ROE -91.6% vs 135%; gross margin 100% vs 94.6%; operating margin -80.8% vs -151.9% — IBRX takes 3 of 5 decided legs, not all of them |
| Valuation | DTIL | Value 60 vs 34 |
| Technicals | IBRX | Price vs 50-day -8.5% vs 0.9%; vs 200-day 17% vs 16.4% |
| Risk Resilience | DTIL | Risk Resilience 51 vs 28 |
| Analyst expectations | DTIL | Target upside 178.9% vs 51.7% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of DTIL and IBRX and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 7 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on IBRX.
How the comparison changed
119 daily snapshots · May 4 – Sep 10IBRX lead: Strengthening — the AIQ differential moved from 3 to 7 points over 30 sessions.
- Today
- IBRX +7
- 49 vs 56
- 7 sessions ago
- IBRX +8
- 53 vs 61
- 30 sessions ago
- IBRX +3
- 61 vs 64
- 90 sessions ago
- IBRX +5
- 61 vs 66
The lead changed hands 4 times in this window, most recently on Jul 20 when IBRX moved ahead of DTIL.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish / 2 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (26.60%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
2 bullish / 1 bearish / 1 neutral, conflicted
- Golden Cross Active — bullish, trend, long horizon (17.25%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.25%)
IBRX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.97%, AIQ 0 points).
Price is up while the AIQ Score moved down 4 points over the same session — price and model disagree (price +2.46%, AIQ -4 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1DTIL closes the Quality gap — currently 49 points behind, the largest single contributor to IBRX's edge.
- 2DTIL's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3IBRX's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
IBRX leads on balance| Metric | DTIL | IBRX |
|---|---|---|
| Revenue growth (YoY) | -100% | 15.9% |
| EPS growth (YoY) | -68% | 64.5% |
| Gross margin | 100% | 94.6% |
| Operating margin | -80.8% | -151.9% |
| Return on equity (TTM) | -91.6% | 135% |
| Debt to equity | 0.62 | -0.78 |
Performance
Split across windows| Metric | DTIL | IBRX |
|---|---|---|
| 1 week (5 sessions) | -2.8% | -2.9% |
| 1 month (20 sessions) | -2.4% | -0.3% |
| 3 months (63 sessions) | 12.2% | 10.6% |
| 6 months (126 sessions) | 43.1% | -6.7% |
| Year to date | 74% | 289.9% |
| 1 year (252 sessions) | 45.7% | 220.3% |
Technicals
IBRX has the stronger structure| Metric | DTIL | IBRX |
|---|---|---|
| RSI (14) | 15.4 | 47.9 |
| ADX (14) | 16.9 | 21.3 |
| Price vs 50-day | -8.5% | 0.9% |
| Price vs 200-day | 17% | 16.4% |
| Volatility (1M, annualized) | 57.2% | 53% |
Risk
DTIL is the more resilient| Metric | DTIL | IBRX |
|---|---|---|
| Beta | 1.15 | 1.61 |
| Sharpe ratio | 0.79 | 1.5 |
| Sortino ratio | 1.32 | 3.05 |
| Max drawdown | -58.5% | -42.3% |
| Current drawdown | -22% | -33.2% |
| Annualized volatility | 72.1% | 104.5% |
| Value at risk (95%) | -7.5% | -7.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, DTIL or IBRX?
On the Algovestiq AIQ Score, IBRX is the stronger of the two as of Sep 11, 2026, scoring 56 against DTIL's 49. The edge comes from quality and momentum. DTIL is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is DTIL or IBRX the better buy right now?
IBRX carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor IBRX over DTIL?
The composite weights Quality, Value, Momentum and Risk Resilience. IBRX leads Quality by 49 points; DTIL leads Value by 26 points; DTIL leads Risk Resilience by 23 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, DTIL or IBRX?
Analyst price targets imply +178.9% upside for DTIL and +51.7% for IBRX, so the Street currently favors DTIL. That points the opposite way to the AIQ Score, which favors IBRX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, DTIL or IBRX?
DTIL is the better-valued of the two on the peer-relative Value factor. DTIL on the peer-relative Value factor, by 26 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, DTIL or IBRX?
IBRX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, DTIL or IBRX?
IBRX on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, DTIL or IBRX?
DTIL is the more resilient of the two, so the other name carries the higher downside risk. DTIL on Risk Resilience, by 23 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is DTIL more profitable than IBRX?
The profitability evidence is mixed: gross margin 100% vs 94.6%; operating margin -80.8% vs -151.9%; ttm roe -91.6% vs 135%. DTIL leads on two measures and IBRX on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is IBRX's lead over DTIL getting stronger or weaker?
IBRX lead: Strengthening — the AIQ differential moved from 3 to 7 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 4 times in that window, most recently on 2026-07-20, when IBRX moved ahead of DTIL.
What would change the DTIL vs IBRX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: DTIL closes the Quality gap — currently 49 points behind, the largest single contributor to IBRX's edge; DTIL's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; IBRX's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about DTIL and IBRX?
DTIL: 2 bullish / 1 bearish / 2 neutral, conflicted. IBRX: 2 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on DTIL is Golden Cross Active (bullish, long horizon). On IBRX it is Golden Cross Active (bullish, long horizon).
Compare DTIL and IBRX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.